ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Balance Sheet
NASDAQ:ZYBT • KYG989MS1016
Current stock price
0.843 USD
0 (-0.31%)
At close:
0.7809 USD
-0.06 (-7.37%)
After Hours:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 45.61M | 18.60M | 15.10K | 9.80K | 6.30K | |||
| Marketable Securities | 2.02M | 1.43M | 1.22M | 0.00 | 0.00 | |||
| Receivables | 62.19M | 88.52M | 99.42M | 134.25M | 102.20K | |||
| Inventories | 53.55M | 58.22M | 58.30M | 55.42M | 43.60K | |||
| Other Current Assets | 38.08M | 10.79M | 15.22M | 14.89M | 12.90K | |||
| Total Current Assets | 201.45M | 177.57M | 189.24M | 214.31M | 164.90K | |||
| Non-Current Assets | ||||||||
| PPE Net | 246.70M | 255.16M | 263.25M | 275.23M | 255.10K | |||
| Intangibles | 23.17M | 22.78M | 24.48M | 27.90M | 12.10K | |||
| Other Non-Current Assets | 33.31M | 37.74M | 22.91M | 2.23M | 13.20K | |||
| Total Non-Current Assets | 303.18M | 315.68M | 310.65M | 305.37M | 280.40K | |||
| TOTAL ASSETS | 504.63M | 493.25M | 499.89M | 519.67M | 445.30K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 81.06M | 81.63M | 79.86M | 54.89M | 30.00K | |||
| Accrued Expenses | 604.00K | 2.82M | 10.00K | 3.46M | 3.30K | |||
| Accounts Payable | 42.80M | 42.96M | 45.66M | 79.28M | 77.60K | |||
| Other Current Liabilities | 10.37M | 8.49M | 24.70M | 14.60M | 14.80K | |||
| Total Current Liabilities | 134.84M | 135.91M | 150.23M | 152.23M | 125.60K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.70M | 4.80M | 9.99M | 9.99M | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 393.00K | 590.00K | 800.00 | |||
| Total Non-Current Liabilities | 70.87M | 73.38M | 76.81M | 70.95M | 52.20K | |||
| TOTAL LIABILITIES | 205.70M | 209.29M | 227.04M | 223.18M | 177.80K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 59.13M | 80.80M | 69.69M | 93.34M | 64.30K | |||
| Additional Paid In Capital | 240.75M | 203.15M | 203.15M | 203.15M | 203.20K | |||
| Minority Interest | 66.17M | 68.58M | 66.42M | 60.37M | 51.40K | |||
| Common Shares | 8.00K | 8.00K | 8.00K | 8.00K | 0.00 | |||
| Other Shareholders' Equity | -966.00K | 3.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 47.39M | 47.17M | 47.17M | 47.17M | 47.17M | |||
| Tangible Book Value per Share | 5.82 | 5.54 | 5.27 | 5.69 | 0.01 | |||
| Total Shareholders' Equity | 298.92M | 283.96M | 272.85M | 296.50M | 267.50K | |||
| TOTAL LIABILITIES AND EQUITY | 504.63M | 493.25M | 499.89M | 519.67M | 445.30K | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.04 | 0.03 | N/A | |||
| Current Ratio | 1.49 | 1.31 | 1.26 | 1.41 | 1.31 | |||
| Return On Assets (ROA) | -2.05% | 2.29% | 6.29% | 8.99% | 10.44% | |||
| Return On Equity (ROE) | -3.46% | 3.98% | 11.53% | 15.76% | 17.38% | |||
| Return On Invested Capital (ROIC) | N/A | 3.63% | 10.17% | 14.15% | 13.32% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 3.65% | 10.20% | 14.15% | 13.32% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | 3.90% | 10.97% | 15.32% | 13.84% | |||
All data in CNY , ROIC based on taxRate of 0.21